Search for: "3M Pharmaceuticals"
Results 61 - 80
of 84
Sorted by Relevance
|
Sort by Date
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
14 Feb 2007, 7:56 am
The New Jersey-based pharmaceutical company also plans to recommend that shareholders vote to reduce the 80 percent supermajority requirement to simple majority approval for the removal of directors, and for mergers and acquisitions. [read post]
24 Apr 2020, 6:58 am
Similarly, 3M has apparently been unable to meet demand for its patented N95 respirators, leading Governor Beshear of Kentucky to call on 3M to license its patents to competitor manufacturers to increase supply.Circumstances like these suggest an unusual use of section 1498 to increase supply: it could be used to make “surgical strikes” where there is a need move quickly to expand supply of patented products—e.g., ventilators to New Orleans, say, or diagnostic… [read post]
20 Jun 2011, 2:01 pm
Withdrawal agreements were reached at all but 3M, where the proposal received 35.8 percent support. [read post]
27 Apr 2007, 12:04 pm
Griswold, 3M, for the 21st Century Patent Coalition spoke, as usual, strongly opposing any "s [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
28 Feb 2024, 2:00 pm
(Kaye and Freedman, Reference Guide on Statistics, in Reference Manual on Scientific Evidence (3d ed. 2011) 211, 217–218 (Statistics); accord Amador v. 3M Co. [read post]
20 May 2020, 1:58 pm
The FDA’s Orange and Purple Books list the patents associated with FDA-approved pharmaceutical products. [read post]
10 Jul 2008, 5:31 pm
Merrell Dow Pharmaceuticals, Inc., 569 N.E.2d 875, 878-79 (Ohio 1991).Oklahoma: Edwards v Basel Pharmaceuticals, 933 P.2d 298, 300-01 (Okla. 1997); Tansy v. [read post]
1 Mar 2021, 7:49 am
The top assignees from the sector are 3M, Align Technology, Ivoclar Vivadent, Philips, and Warsaw Orthopedic. [read post]
10 Mar 2010, 6:03 pm
The products involved in these cases run the gamut from Rubik’s Cube, the X-Box, and Post-it Notes, to Viagra, other pharmaceuticals and every type of semiconductor device. [read post]
21 Apr 2011, 1:36 pm
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
20 May 2012, 1:11 pm
In the pharmaceutical industry, once you have carved out your monopoly with patent protection and your drug has proved safe and effective in a patent's care plan, it is difficult for subsequent and competitive drugs to overtake that established market share even when your patent protection expires. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
15 Jan 2008, 3:06 am
There were 140 patent cases filed in the Northern District during 2007, an 11% increase from the 126 patent cases filed in 2006. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
1 Jan 2019, 5:10 pm
Congress included co-pay requirements in the Medicare program, in part, to serve as a check on health care costs, including the prices that pharmaceutical manufacturers can demand for their drugs. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
24 Apr 2020, 3:00 am
Hospitals, casinos, Indian tribes, pharmaceutical interests, and private equity firms have all hired lobbyists for help, along with companies from 3M to Ticketmaster to Six Flags. with companies from 3M to Ticketmaster to Six Flags. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
